Agenovir Corporation

Agenovir is developing a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs

Focus area
Infectious Diseases & Vaccines
Graduation date
06/12/2017
Commencement date
09/21/2015